Background. Hepatitis C Virus (HCV) infection causes substantial morbidity and mortality among HIV-infected persons. Representative prevalence estimates of HCV infection can help inform treatment efforts in the dawning era of highly effective anti-HCV therapy.
Methods. We used 2009 data from the Medical Monitoring Project, a nationally representative sample of U.S. HIV-infected adults in care, to determine prevalence of HCV testing and infection. We defined HCV testing as documentation of an HCV antibody or RNA test and HCV infection as a positive result. We used bivariate analyses and multivariate logistic regression to examine factors associated with HCV testing and infection.
Results. We estimated that 342,952 HIV-infected adults or 81% (95% confidence intervals [CIs] : 304,474-381,430; 79%-84%) were ever tested for HCV. Factors associated independently ( p <0.01) with testing included black race, recent HIV diagnosis, and history of AIDS. Among those tested, 21% (95% CI: 18-24%) were infected with HCV. Prevalence varied significantly by age (≥ 44 vs < 44 years: 27 vs 10%), men who have sex with women only (MSW) vs men who have sex with men (MSM) (33 vs 14%), public vs private insurance (28 vs 11%), income at or below poverty level vs not (28 vs 16%), homeless vs not (34 vs 20%), recent injection drug use (IDU) vs not (62 vs 20%), duration of HIV infection (≥ 10 vs <10 years: 27 vs 14%), and history of AIDS vs no AIDS (23 vs 17%). Factors associated independently with HCV infection included recent IDU (adjusted prevalence ratio [APR] 3.2; 95% CI 2.6-3.9), age >44 years (APR 2.2; 95% CI 1.7-2.7], MSW (APR 1.9; 95% CI 1.6-2.3), public insurance (APR 1.6; 95% CI 1.3-2.1), HIV diagnosed ≥10 years (APR 1.5; 95% CI 1.3-1.8), homelessness (APR 1.4; 95% CI 1.1-1.7), and income at or below poverty level (APR 1.3; 95% CI 1.1-1.5).
Conclusion. Current U.S. guidelines endorse baseline HCV screening for all HIVinfected persons and routine screening for those with IDU; however, almost 1 in 5 U.S. HIV-infected adults in care have never been tested. HCV infection prevalence varied among sub-groups. All HIV-infected adults, especially those in high-risk groups, should be tested for HCV to increase the number of persons aware of their HCV infection and eligible for potentially curative treatment.
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